We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 1,123

Inventive step: how high is the obviousness threshold?
  • Bird & Bird
  • Australia
  • July 2 2015

As part of the long running legal battle in Australia concerning the validity (and infringement) of a series of second generation patents in respect


Full Court dismisses Garford’s appeal and upholds decision that patent claims are invalid
  • Davies Collison Cave
  • Australia
  • July 2 2015

The Full Federal Court has dismissed an appeal by Garford against the decision by Yates J that claims of its patent were invalid, and that it made


High Court considers inventive step in Australia
  • Spruson & Ferguson
  • Australia
  • June 26 2015

Last month, on 13 and 14 May 2015, the High Court of Australia heard the Appeal in the rosuvastatin case from the Full Federal Court decision


High Court of Australia hears Myriad appeal
  • Spruson & Ferguson
  • Australia
  • June 16 2015

The High Court of Australia today heard the long anticipated appeal from the unanimous decision of a 5-judge bench of the Full Federal Court to allow


Pharmaceutical patentee faces damages claim from Australian government for blocking generic’s entry
  • Fisher Adams Kelly
  • Australia
  • June 16 2015

A series of events has led to the Commonwealth of Australia attempting to recover damages from the bio pharma company, Sanofi-Aventis, to the tune of


High Court to consider if isolated genes are patentable
  • Gilbert + Tobin
  • Australia
  • June 15 2015

The High Court will hear oral argument in the D'Arcy v. Myriad Genetics Inc & Anor appeal on Tuesday, 16 - Wednesday, 17 June 2015 before all 7 High


An expensive lesson in licensing when exclusively performing an act does not make you an exclusive licensee
  • Baldwins
  • Australia, New Zealand
  • June 10 2015

It's generally well understood that in a number of jurisdictions an exclusive licensee can initiate infringement proceedings. However, the recent


High Court date set: to patent or not to patent isolated DNA?
  • Watermark Patent & Trade Marks Attorneys
  • Australia
  • May 29 2015

The date is set. The High Court of Australia will begin proceedings on 16 June 2015 to ultimately decide the patentability of isolated genetic


A myriad of problems and opportunities a comparison of the patentability of isolated nucleic acid in the United States and Australia
  • DLA Piper LLP
  • Australia, USA
  • May 6 2015

Due to the inherent nature of the technologies that underpin it, the biotechnology industry has faced challenges worldwide in relation to precisely


Could the courts compel prescribers and dispensers of medicines to help big pharma fight generics?
  • Watermark Patent & Trade Marks Attorneys
  • Australia, United Kingdom
  • May 6 2015

A recent UK court ruling broke new ground in ordering an official health body to issue guidelines on prescribing a generic drug. Could the same thing